From January 1, 2023 to March 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 11,937,264 shares, representing 1.04% for CNY 170.04 million under the buyback announced on May 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.4 CNY | -0.45% | -2.12% | -11.49% |
05-23 | Aodong Medicine Industry's Unit Gets Certificates for 10 Traditional Chinese Medicines | MT |
05-20 | Jilin Aodong Pharmaceutical Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.49% | 2.21B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.